1 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Alveolar Soft Part Sarcoma: new trials by email Literature Review of Alveolar Soft Part Sarcoma trials Research Report on Alveolar Soft Part Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) AL3818, Dacarbazine, AL3818 or placebo - Alveolar Soft Part Sarcoma, Leiomyosarcoma | Phase 3 | Recruiting | Advenchen Laboratories, LLC | 325 | 2017-08-15 | 2026-02-25 |
| Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Doxorubicin, Doxorubicin Hydrochloride, Ifosfamide - Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma | Phase 2 / Phase 3 | Completed | National Cancer Institute (NCI) | 140 | 2014-08-12 | 2026-06-17 |
Leiomyosarcoma (2) · Sarcoma (2) · Sarcoma, Alveolar Soft Part (2) · Sarcoma, Synovial (2) · Chondrosarcoma, Extraskeletal Myxoid (1) · Chondrosarcoma, Mesenchymal (1) · Dermatofibrosarcoma (1) · Fibrosarcoma (1) · Granuloma, Plasma Cell (1) · Histiocytoma, Angiomatoid Fibrous (1) · Histiocytoma, Malignant Fibrous (1) · Liposarcoma (1) · Nerve Sheath Neoplasms (1) · Neurofibrosarcoma (1) · Perivascular Epithelioid Cell Neoplasms (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Muscle Tissue (2) · Chondrosarcoma (1) · Granuloma (1) · Histiocytoma (1) · Neoplasms, Adipose Tissue (1) · Neoplasms, Fibrous Tissue (1) · Neoplasms, Nerve Tissue (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neurofibroma (1) · Neuromuscular Diseases (1)
Dacarbazine (1) · Digoxin (1) · Doxorubicin (1) · Ifosfamide (1) · Midazolam (1) · Radiation (1) · Radiotherapy (1) · Rosuvastatin Calcium (1) · Tablets (1) · anlotinib (1) · pazopanib (1)
Advenchen Laboratories, LLC (1) · National Cancer Institute (NCI) (1)
United States (2) · Canada (1) · China (1) · Italy (1) · Puerto Rico (1) · Spain (1) · United Kingdom (1)
Aaron R Weiss (1)
PMID 32702309, PMID 32827353, PMID 34515544, PMID 37523624
U10CA098543 (1), U10CA180830 (1), U10CA180886 (1)